BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 106286
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.106286
Table 1 Clinical and pathological data of two groups of gastric cancer patients, mean ± SD
Baseline information
ERAS group (n = 40)
Traditional treatment group (n = 40)
P value
Age (year)61.81 ± 4.6260.21 ± 5.120.41
Gender (male/female)32/834/60.45
BMI (kg/m2)24.32 ± 3.1323.31 ± 2.820.71
Tumor site0.79
Upper part of stomach52-
Mid stomach1010-
Lower part of stomach2528-
Surgical time (minute)220.71 ± 30.41232.73 ± 32.010.61
Tumor size (cm)3.81 ± 1.723.91 ± 1.660.59
Degree of tumor differentiation0.66
Well differentiated23-
Moderately differentiated1516-
Poorly differentiated2018-
Signet-ring cell carcinoma23-
Mucinous cell carcinoma10-
Lauren classification
Intestinal2830-
Diffuse57-
Mixed type73-
TNM stage
I23-
II1314-
III2523-
IV00-


Write to the Help Desk